Structural differences of amyloid-β fibrils revealed by antibodies from phage display
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural differences of amyloid-β fibrils revealed by antibodies from phage display
Authors
Keywords
Alzheimer’s disease, Aβ, Abeta, Beta-amyloid, Phage display, Immune library, scFv
Journal
BMC BIOTECHNOLOGY
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-17
DOI
10.1186/s12896-015-0146-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B
- (2014) Manon Fuchs et al. BMC BIOTECHNOLOGY
- Human-like antibodies neutralizing Western equine encephalitis virus
- (2014) Birgit Hülseweh et al. mAbs
- Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library
- (2014) Sebastian Miethe et al. mAbs
- High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
- (2013) Volker Jäger et al. BMC BIOTECHNOLOGY
- Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer’s Disease?
- (2013) Silke Dornieden et al. PLoS One
- Human LilrB2 Is a -Amyloid Receptor and Its Murine Homolog PirB Regulates Synaptic Plasticity in an Alzheimer's Model
- (2013) T. Kim et al. SCIENCE
- Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
- (2013) Niels D Prins et al. Alzheimers Research & Therapy
- Brain Imaging in Alzheimer Disease
- (2013) K. A. Johnson et al. Cold Spring Harbor Perspectives in Medicine
- Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
- (2013) Jens Moreth et al. Immunity & Ageing
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
- (2012) Torsten Rülker et al. PLoS One
- Perspective: In search of biomarkers
- (2011) Neil S. Buckholtz NATURE
- Beyond natural antibodies: the power of in vitro display technologies
- (2011) Andrew R M Bradbury et al. NATURE BIOTECHNOLOGY
- Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species
- (2010) Asad Jan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A human scFv antibody generation pipeline for proteome research
- (2010) Michael Hust et al. JOURNAL OF BIOTECHNOLOGY
- Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics
- (2010) Thibaut Pelat et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
- (2010) Mahiuddin Ahmed et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta
- (2010) Vitaly Vasilevko et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
- (2009) Thibaut Pelat et al. BMC BIOTECHNOLOGY
- Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus
- (2009) Mark Schütte et al. PLoS One
- The Ratio of Monomeric to Aggregated Forms of Aβ40 and Aβ42 Is an Important Determinant of Amyloid-β Aggregation, Fibrillogenesis, and Toxicity
- (2008) Asad Jan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aβ(1-40) Fibril Polymorphism Implies Diverse Interaction Patterns in Amyloid Fibrils
- (2008) Jessica Meinhardt et al. JOURNAL OF MOLECULAR BIOLOGY
- Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
- (2008) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers
- (2008) R. Robert et al. PROTEIN ENGINEERING DESIGN & SELECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More